If you or a family member have myotonic dystrophy, the #1 thing you can do to help researchers develop an effective treatment is to enroll in the END-DM1 natural history study. Details here: https://t.co/pufFFBh0Fx
Dyne Therapeutics Announces Completion of Enrollment in Registrational Expansion Cohort of ACHIEVE Trial of Z-Basivarsen for Myotonic Dystrophy Type 1 (DM1) https://t.co/lqj0XwojVD
Emory/Univ. of Florida study: Muscleblind-like proteins dimerize by forming disulfide bonds to regulate alternative splicing and pathogenic RNA foci formation https://t.co/paWx2sfOp3
Chinese study: A pilot study on the application of Oxford Nanopore PromethION sequencing with adaptive sampling for DMPK repeat expansion sizing in myotonic dystrophy type 1 https://t.co/g8TESCFNEA
PR: ARTHEx Biotech Delivers Multiple Presentations at IDMC-15 Highlighting Clinical Progress of ATX-01 and Mechanistic Insights for Myotonic Dystrophy Type 1 (DM1) and 2 (DM2) https://t.co/60iO2YGRgY
At the International Myotonic Dystrophy Consortium this week, Domi Stickens, PhD, Chief Scientific Officer, presents a poster on our RNA-targeted small-molecule therapeutics and the first oral therapy in development for myotonic dystrophy type 1 #DM1. #IDMC15#MyotonicDystrophy
Very interesting Turkish study: Evaluating the performance of ChatGPT in responding to myotonic dystrophy type 1 patient inquiries: a specialist physician-based study https://t.co/nhRoumjQLC
I almost hesitate to promote this, because it wasn't really intended to be a piece. I just sort of sat down and it came out. Maybe someone else out there has the same type of day today, and it'll speak to them.
https://t.co/xSMUDOrHcC
$PEPG - PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGNEDODM1 Program
News & Disclaimer
https://t.co/K9DPB6wafL
A chemoinformatics-guided platform for efficient discovery of RNA-binding small molecules: Proof-of-concept for myotonic dystrophy type 1 | bioRxiv https://t.co/cvUBam6LX0
Int'l study: Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1 https://t.co/lIsyQ7Po0G
Myotonic dystrophy-related abstracts from Modalis/Affinia (#1492), Univ. of Washington (#2502) and Ascidian (#2471) at ASGCT conference https://t.co/MfHx8clTbu
Fiscone et al. used quantitative susceptibility mapping to measure iron in cortical and subcortical regions of patients with myotonic dystrophy type 1. They observed increased iron in the thalamus and brainstem 👉 https://t.co/RB1U3i44yN
#braincommunications
There are many sterile stories about the farm crisis, and what tariffs and war have done to exacerbate it.
If you read one story on the subject, it should be this one, about the final days of a multi-generational family farm.
It'll rip your heart out.
https://t.co/wOQPaQIYQO via @NYTimes